Motivated by this finding, we propose that in ischemic tissues, the downregulation of let-7 leads to higher AGO1 level and weakens the pathway of AGO1-mediated VEGF release as described in our model, thereby resulting in impaired angiogenesis and hindered perfusion recovery in PAD patients. Here, VEGFA is linked to peripheral arterial disease.